Accelerated Transcranial Magnetic Stimulation Intervention for Post-Concussion Syndrome
Functional MRI Guided Accelerated Intermittent Theta Burst Stimulation for Chronic Post-Concussive Syndrome: A Feasibility and Efficacy Retrospective Chart Review
2 other identifiers
observational
11
1 country
1
Brief Summary
This study looks at the effects of accelerated intermittent theta burst stimulation (aiTBS) on patients with chronic and acute post-concussion syndrome. Each participant was treated in an outpatient setting for about 3 hours per day, over 3 days. The participants' symptom survey scores and brain scan data were then compared before and after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedFirst Submitted
Initial submission to the registry
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
October 8, 2025
CompletedOctober 10, 2025
October 1, 2025
2 months
October 1, 2025
October 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Post-Concussion Symptom Scale (PCSS) Score
PCSS (post-concussion symptom scale) is a 21-question Likert scale questionnaire regarding physical, cognitive, sleep, and emotional symptoms of post-concussion syndrome. Minimum score on the scale is zero, maximum score is 126. Higher score indicates more severe symptoms.
Scores taken prior to intervention, immediately post-intervention, and 1-4 weeks post-intervention
Beck Anxiety Inventory (BAI) Score
Beck Anxiety Inventory is a 21-question Likert scale questionnaire used for measuring severity of anxiety symptoms. Minimum score is zero, maximum score is 63. Higher score indicates more severe symptoms.
Immediately prior to treatment, after treatment, and 1-4 weeks post-treatment
Beck Depression Inventory (BDI) Score
Beck Depression Inventory is a 21-question multiple choice self-report inventory used for measuring severity of depression. Minimum score is zero, maximum score is 63. Higher scores indicate more severe symptoms.
Pre-treatment, immediately post-treatment, and 1-4 weeks post-treatment.
Functional Neurocognitive Imaging (fNCI) Score
The fNCI assessment protocol combines the validity of conventional neuropsychological testing standards with the reliability and objectivity of informational data output provided by fMRI. It is a scan comparing BOLD signal and blood flow from participant's brain scan against a normative database of healthy, non-injured brains. Higher scores represent further deviation from healthy baseline, with a minimum score of zero and no theoretical maximum score. Scores below 1 are within healthy range.
1-4 weeks pre-treatment, 1-4 weeks post-treatment
Study Arms (1)
Post-Concussion Symptom Participants
Participants experiencing chronic or acute symptoms resulting from a mild traumatic brain injury
Eligibility Criteria
Participants were primarily recruited from referrals to Neural Effects (an insurance-based acute concussion care center tied to Cognitive FX). Additional patients were recruited from word-of-mouth referrals to our clinic for concussion care.
You may qualify if:
- Chronic or acute concussion symptoms
You may not qualify if:
- MDD, GAD, bipolar depression, PTSD, schizophrenia, metal implants in skull, pacemaker, history of seizures, epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cognitive FXlead
Study Sites (1)
Cognitive FX TMS Clinic
Provo, Utah, 84604, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Allen, PhD
Cognitive FX
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2025
First Posted
October 8, 2025
Study Start
May 1, 2025
Primary Completion
June 30, 2025
Study Completion
July 31, 2025
Last Updated
October 10, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared unless other researchers sign a data use agreement outlining a plan to use IPD that does not include any form of identifiable PHI.